Jagsonpal Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Present Capital
Equibles does not estimate personal net worth.
Vansh Gupta is recorded as Analyst at Present Capital. Vansh Gupta has spoken on 3 earnings calls across 3 companies, most recently for Jagsonpal Pharmaceuticals Limited on October 29, 2026. Those appearances were for Jagsonpal Pharmaceuticals Limited, Travel Food Services Limited and Innova Captab Limited. The companies whose calls Vansh Gupta spoke on are classified in the Healthcare and Consumer Cyclical sectors.
“So, last quarter of the week spoke about the brand premiumization in our portfolio, which I believe the management of that would lead to higher gross margins. However, if I look at our gross margin on the stand-alone business, they've hovered around 60-65% for the last eight-nine quarters.”
“So, just a couple of questions for mine. Given that... Some of our airports, like the Delhi T3 airport, they might be moving towards the JV, and given that Delhi and Mumbai airports are perhaps the two biggest airports in the country, then they should be contributing to a large part of their revenue and margins.”
“So, we had about 200 odd crores of growth in the CDMO business year-on-year. Was the majority of this growth driven by a domestic business or was the majority of it driven by an export business?”
Present Capital
Analyst
Transcript header (unverified)
Jagsonpal Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Travel Food Services Limited
Restaurants · Consumer Cyclical
Innova Captab Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Jagsonpal Pharmaceuticals Limited
Earnings Call for the Quarter Ended June 30, 2026
Travel Food Services Limited
“Innova Captab Limited Q4 and FY '26 Earnings Conference Call”
Innova Captab Limited